Showing results (41-50 of 294) with videos related to

Sort By:
Pageof 30
Cancer Letters|February 3, 2015
Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacyRebecca B Schechter, Madhavi Nagilla, Loren Joseph, et al.
Current Opinion in Otolaryngology & Head and Neck Surgery|March 5, 2011
Targeted therapy in head and neck cancerLisa Licitra, Cristiana Bergamini, Aurora Mirabile, et al.
Oral Oncology|December 20, 2008
Survival from salivary glands adenoid cystic carcinoma in European populationsLaura Ciccolallo, Lisa Licitra, Giulio Cantú, et al.
Tumori|May 15, 2002
Clozapine and full-dose concomitant chemoradiation therapy in a schizophrenic patient with nasopharyngeal cancerClaudia Bareggi, Mauro Palazzi, Laura D Locati, et al.
Tumori|January 9, 2026
Generative AI and medical oncologists: Be curious, but cautious!Silvana Quaglini, Lucia Sacchi, Federico Sottotetti, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2018
The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluationMichela Meregaglia, John Cairns, Lisa Licitra, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2023
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumoursPaolo Bossi, Ester Orlandi, Carlo Resteghini, et al.
Head & Neck|February 6, 2016
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancerSalvatore Alfieri, Carla I Ripamonti, Sara Marceglia, et al.
Cancer|May 22, 2014
Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessmentsLaura D Locati, Lisa Licitra, Laura Agate, et al.
IEEE Transactions on Bio-Medical Engineering|August 1, 2002
Forecasting the performance status of head and neck cancer patient treatment by an interval arithmetic pruned perceptronGian Paolo Drago, Ernesto Setti, Lisa Licitra, et al.
Pageof 30